Do you want to read an article? Please log in or register.
Comparing Major COPD Triple Therapy Trials Using a Structured Multi-Criteria Decision Analysis: A Deep Dive into Patient Populations and Outcomes
COPDPneumonia
Related content
COPD
Comparison of the Risk of Pneumonia Between Fluticasone Furoate/Umeclidinium/Vilanterol and Multiple-Inhaler Triple Therapy in Patients with COPD Using Health Insurance Claims Data: Final Analysis of Post-Marketing Database Surveillance in Japan
J Clin Med
Akiyama S, Oda K, Mizohata H, Sasakura N, Hashimoto K, Maruoka H
doi: 10.3390/jcm14134697
COPD
Comparative effectiveness and safety of escalating to triple therapy versus switching to dual bronchodilators after discontinuing LABA/ICS in patients with COPD: a retrospective cohort study
Ther Adv Respir Dis
Wu LW, Lin TC, Lin TH, Liou YJ, Tsai CL, Yang KY, Wang MT
doi: 10.1177/17534666241292242
RECOMMENDED
COPDLung Cancer
Impact of Triple Inhaler Therapy on COPD Patients with Non-Small Cell Lung Cancer After Radical Surgery: A Single-Centre Retrospective Analysis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med
Bertuccio FR, D'Agnano V, Cordoni S, Tafa M, Novy C, Baio N, Mucaj K, Bortolotto C, Melloni G, Bianco A, Corsico AG, Perrotta F, Stella GM
doi: 10.3390/jcm14010249
COPD
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS
Respir Res
Singh D, Bafadhel M, Arya N, Marshall J, Parikh H, Kisielewicz D, Movitz C, Bowen K, Patel M
doi: 10.1186/s12931-025-03234-5
COPD
Preventing oxygen desaturation during bronchoscopy in COPD patients using high flow oxygen versus standard management: the randomised controlled PROSA 2 Trial
Eur Respir J
Darie AM, Grize L, Jahn K, Salina A, Röcken J, Herrmann MJ, Pascarella M, Suarez V, Strobel W, Tamm M, Stolz D
doi: 10.1183/13993003.01586-2024
Pulmonary Hypertension
Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life framework
Eur Respir Rev
Varian F, Burney R, Pearson C, Goh ZM, Newman J, Rawlings G, Zafar H, Kiely DG, Thompson AAR, Condliffe R, Toshner M, McCormack C, Armstrong I, Peasgood T, Carlton J, Rothman AMK
doi: 10.1183/16000617.0006-2025
Asthma
Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A Post-hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
Allergy Asthma Immunol Res
Chen R, Dai Y, Yang D, Liu C, Han W, Gu W, Cao J, Zhou Q, Howarth P, Weng S, Xiong C, Huang J, Liang P, Zhong N, 201536 Study Group
doi: 10.4168/aair.2025.17.4.473
COMMENTED
COPD
Efficacy and safety of ensifentrine in treatment of COPD: a systematic review and meta-analysis of clinical trials
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Ther Adv Respir Dis
Hammadeh BM, Younis OM, Alsufi MI, Idrees M, Hussein AM, Aldalati AY, Qtaishat FA, Qatawneh B, Bugazia A, Hamed RA
doi: 10.1177/17534666251347775
RECOMMENDED
Pulmonary Fibrosis
Self-reported chronic therapy use after 24-weeks of follow-up by participants who completed the simplify randomized, controlled trial
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros
Gifford AH, Odem-Davis K, Kloster M, O'Sullivan BP, Omlor GJ, Millard SL, Clancy JP, Sawicki GS, Riekert K, Mayer-Hamblett N, Nichols DP, SIMPLIFY Study Group
doi: 10.1016/j.jcf.2024.08.008